Fundraising for Biotech during coronavirus - how should founders use it to their advantage, by Jason Scharf.  episode artwork

EPISODE · Jul 9, 2020 · 26 MIN

Fundraising for Biotech during coronavirus - how should founders use it to their advantage, by Jason Scharf.

from The AFT podcast: At the Forefront of Transactions | Payments | Fintech | Pay-tech | Banking · host Konstantin Dubovitskiy

In this episode of Fundraising Radio, Jason Scharf the Associate Director at Illumina and a Co-Fund Manager at San Diego Angel Conference explains how biotech and life-science startups should adapt to the current situation and use it to their advantage and how should other founders make sure they are prepared for the investor's questions regarding covid. Illumina Accelerator - https://www.illumina.com/science/accelerator.html San Diego Angel Conference - http://thesdangels.com/

Episode metadata supplied by the publisher feed · Published Jul 9, 2020

Embed this episode

NOW PLAYING

Fundraising for Biotech during coronavirus - how should founders use it to their advantage, by Jason Scharf.

0:00 26:33

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The AFT podcast: At the Forefront of Transactions | Payments | Fintech | Pay-tech | Banking?

This episode is 26 minutes long.

When was this The AFT podcast: At the Forefront of Transactions | Payments | Fintech | Pay-tech | Banking episode published?

This episode was published on July 9, 2020.

Can I download this The AFT podcast: At the Forefront of Transactions | Payments | Fintech | Pay-tech | Banking episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!